BMAL2 and pachyonychia congenita: GRS which was established based on the expression of ARNTL2 and TPX2 showed the highest positive correlation with the expression of ARNTL2 (R = 0.93, p < 0.001) and ARNTL2 was highly expressed in PC patients with high GRS (Fig. 2F and S1D).